JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.

Dosage - Labelling

Date

2022-08-29

Country

Canada

Product

JAMP ATORVASTATIN CALCIUM

Classification

Type I

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2022-08-31
2. CA
   Drugs & medicalType III

   Menopur: Out of specification (Assay)

   Product quality

   Health CanadaOfficial notice →
3. 2022-08-30
4. CA
   Drugs & medicalType I

   DRAXIMAGE MDP: Affected lot may contain particulate matter

   Product quality

   Health CanadaOfficial notice →
5. 2022-08-29
6. CA
   Drugs & medicalType I

   NERFASIN 20: Affected lot may contain the presence of particles

   Product quality

   Health CanadaOfficial notice →
7. CA
   Drugs & medical

   IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure

   New safety information - Product safety

   Health CanadaOfficial notice →
8. 2022-08-27
9. CA
   Drugs & medical

   Recall of one lot of Jamp-Atorvastatin Calcium as some bottles may be labelled as containing 10 mg tablets, but contain 40 mg tablets

   Dosage - Labelling

   Health CanadaOfficial notice →
10. 2022-08-25
11. CA
    Drugs & medical

    Counterfeit Viagra and Cialis erectile dysfunction drugs seized from Grace Daily Mart in Scarborough, Ontario

    Product safety

    Health CanadaOfficial notice →